News from k-v pharmaceutical company

Jul 10, 2014, 09:00 ET

Takeda and Zinfandel Pharmaceuticals to Present Data at Upcoming Alzheimer's Association International Conference® Highlighting Innovative Approaches to Alzheimer's Disease Research and Development

 Takeda Pharmaceutical Company Limited ("Takeda") and its partner, Zinfandel Pharmaceuticals, Inc. ("Zinfandel"), will present data during...

Jul 09, 2014, 08:00 ET

Par Pharmaceutical Begins Shipment of Fluphenazine Decanoate Injection, USP

Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the U.S. Food and Drug Administration for its...

Jun 17, 2014, 15:53 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Type 2 diabetes: Boehringer Ingelheim and Eli Lilly and Company announce resubmission of New Drug Application for empagliflozin to FDA

 Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (NYSE: LLY) today announced the resubmission of a New Drug...

Jun 17, 2014, 09:00 ET

Results of a New Study of Brintellix® (vortioxetine) vs. Escitalopram on Sexual Functioning in Well Treated MDD Patients Experiencing Treatment-Emergent Sexual Dysfunction

Takeda Pharmaceuticals Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced that the companies will present results about sexual...

Jun 16, 2014, 10:00 ET

ENTYVIO™ (vedolizumab) Now Available in the United States for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis and Crohn's Disease

 Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced the...

Jun 16, 2014, 06:30 ET

New CONNECT Study Presents data on Measures of Cognitive Performance in Adult Patients Treated with Brintellix® (vortioxetine) for Major Depressive Disorder

 Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced results from CONNECT, a new study that evaluated...

Jun 10, 2014, 14:34 ET

Strativa Pharmaceuticals Announces FDA Approval of Nascobal® (Cyanocobalamin, USP) Nasal Spray Single-Use Device

 Strativa Pharmaceuticals, the branded division of Par Pharmaceutical Companies, Inc., today announced that the U.S. Food and Drug...

May 20, 2014, 18:14 ET

FDA Approves Takeda's Entyvio™ (vedolizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the...

May 15, 2014, 12:45 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Type 2 diabetes: findings presented from retrospective analysis of pooled data examining linagliptin in African-American adults

Data from a retrospective pooled analysis of eight phase III trials (two 18-week and six 24-week) of linagliptin 5 mg once-daily, showed...

May 09, 2014, 09:00 ET

Pharmaceutical Executive Paul Williams Joins K-V Pharmaceutical Company as Head of Women's Healthcare Division

 Today, K-V Pharmaceutical Company ("KV") announced that Paul Williams – a seasoned executive with extensive experience in both neonatal...

May 07, 2014, 11:34 ET

Par Pharmaceutical Announces Quarterly Conference Call

Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Friday, May 16, 2014 at 9:30 a.m. EDT to review its...

Apr 14, 2014, 09:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Boehringer Ingelheim and Eli Lilly and Company Announce New Drug Application Filing in the U.S. for the Combination Tablet of Empagliflozin and Linagliptin

 Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (Lilly; NYSE: LLY) today announced the U.S. Food and Drug Administration...

Apr 07, 2014, 10:08 ET

Par Pharmaceutical Begins Shipment of Potassium Chloride Extended-Release Capsules

WOODCLIFF LAKE, N.J., April 7, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the...

Apr 01, 2014, 08:30 ET

Par Pharmaceutical Names Terrance J. Coughlin Chief Operating Officer

 Par Pharmaceutical Companies, Inc. today announced that Terrance J. Coughlin has been named chief operating officer.  In this capacity,...

Mar 27, 2014, 08:00 ET

Takeda Presents Additional Data from the EXAMINE Cardiovascular Safety Outcomes Trial at the American College of Cardiology's 63rd Annual Scientific Session

Takeda Pharmaceutical Company Limited (Takeda) will present sub-analyses from the global EXAMINE (EXamination of CArdiovascular OutcoMes:...

Mar 24, 2014, 08:00 ET
Janssen Logo.  (PRNewsFoto/Janssen Pharmaceutical Companies)

Janssen to Present New Simeprevir Data at The International Liver Congress™ 2014 of the European Association for the Study of the Liver (EASL)

 New data from the clinical development program for Janssen's protease inhibitor simeprevir in the treatment of genotype 1 chronic hepatitis C...

Mar 13, 2014, 13:33 ET

Par Pharmaceutical Announces Fourth Quarter and Full Year 2013 Conference Call

 Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Thursday, March 20, 2014 at 10:00 a.m. EDT to...

Mar 05, 2014, 09:30 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

U.S. Food and Drug Administration Issues Complete Response Letter for Empagliflozin

 Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (Lilly; NYSE: LLY) today announced the U.S. Food and Drug...

Feb 21, 2014, 09:00 ET

K-V Pharmaceutical Company Appoints Healthcare Veteran, Gregg Raybuck, to Lead New Maternal Health Division

K-V Pharmaceutical Company ("KV") announced today that Gregg Raybuck, a healthcare veteran with extensive experience in women's and children's...

Jan 21, 2014, 13:41 ET

New Nanoparticle Therapy Reduces Damage After Heart Attack

 Cour Pharmaceutical Development Company, Inc., a biopharmaceutical company, announced today the publication of new data in Science...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer